New Key Statistics Module, Z-Score and F-Score
NAS:CTIC Key Ratios
Market Cap $ M | 1,198.79 |
Enterprise Value $ M | 1,188.67 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 14.88 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 75.00 |
EPS (TTM) $ | -0.58 |
Beneish M-Score | 26.13 |
10-y EBITDA Growth Rate % | 26.10 |
5-y EBITDA Growth Rate % | -0.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -22.80 |
EV-to-EBITDA | -23.78 |
PEG | -- |
Shares Outstanding M | 131.88 |
Net Margin (%) | -91.38 |
Operating Margin % | -71.18 |
Pre-tax Margin (%) | -91.38 |
Quick Ratio | 1.26 |
Current Ratio | 1.27 |
ROA % (ttm) | -55.16 |
ROE % (ttm) | -- |
ROIC % (ttm) | -93.31 |
Dividend Yield % | -- |
Altman Z-Score | -27.01 |
CTIC Number of Guru Trades
CTIC Volume of Guru Trades
Gurus Latest Trades with NAS:CTIC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:CTIC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
CTI BioPharma Corp Insider Transactions
No Available Data
News about NAS:CTIC
Total 0- 1